Experimental models have demonstrated that genetic ablation of inflammasome components—such as NLRP3, caspase-1, caspase-11, or GSDMD—confers protection against sepsis-induced mortality by attenuating systemic inflammation, coagulopathy, and multiorgan dysfunction. The gene discussed is CASP1; the disease is Sepsis.